SCC-7 Cells
USUSD$540.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
一般資訊
| 說明 | The SCC-7 (or SCC-VII) cell line is a murine squamous cell carcinoma model derived from the spontaneous tumor of a C3H mouse. It has been widely utilized in cancer research, particularly for studies involving tumor radiation responses, chemotherapy, and hypoxia-related resistance mechanisms. SCC-7 is known for its adaptability in syngeneic C3H mice, where it forms solid tumors upon subcutaneous inoculation. This characteristic makes it a suitable preclinical model for evaluating therapeutic interventions and understanding the cellular responses to treatment. Studies on SCC-7 tumors have demonstrated their heterogeneity in sensitivity to chemotherapeutic agents. For instance, in experiments evaluating the cytotoxic effects of CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea), SCC-7 showed enhanced sensitivity when treated in combination with the hypoxic radiosensitizer misonidazole. The addition of misonidazole increased the cytotoxic effects of CCNU, potentially due to the enhancement of DNA crosslinking or inhibition of DNA repair mechanisms under hypoxic conditions. Importantly, the enhancement ratio for SCC-7 was reported to be approximately 1.7 to 1.8, indicating a significant increase in tumor cell killing. SCC-7 tumors are often used to explore the impact of hypoxia on treatment resistance. These tumors display characteristics of hypoxic regions, which mimic the clinical challenge of oxygen deprivation within solid tumors. The tumor's clonogenic potential is also assessed through survival assays, which determine the fraction of viable cells post-treatment, providing critical insights into treatment efficacy. SCC-7 serves as a robust preclinical model for squamous cell carcinoma research. Its use in radiation biology, hypoxia studies, and chemotherapeutic evaluation has contributed significantly to understanding tumor responses to therapy and developing strategies to overcome treatment resistance. |
|---|---|
| 生物體 | Mouse |
| 組織 | Abdominal wall |
| 疾病 | squamous cell carcinoma |
| 同義詞 | SCC-7, SCCVII/St, SCCVII, SCC VII |
特徵
| 品種/亞種 | C3H |
|---|---|
| 年齡 | Unspecified |
| 性別 | Unspecified |
| 形態學 | Epithelial-like |
| 生長特性 | Adherent |
監管數據
| 引用 | SCC-7 (Cytion catalog number 305622) |
|---|---|
| 生物安全等級 | 1 |
| NCBI_TaxID | 10090 |
| Cellosaurus 編號 | CVCL_V412 |
生物分子資料
處理方式
| 培養基 | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| 營養補充品 | Supplement the medium with 10% FBS |
| 解離試劑 | Accutase |
| 播種密度 | 1 to 3 x 104 cells/cm2 |
| 流體更新 | 2 to 3 times per week |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
品質控制與分子分析
| 不孕症 | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
分析證明書 (CoA)
| 批次編號 | 證書類型 | 日期 | 型號 |
|---|---|---|---|
| 305622-160326 | 分析證明書 | 13. Apr. 2026 | 305622 |